The treatment of tumor-bearing mice with NGF resulted in a reduction of tumor volume by 72%, increased lymphocytic infiltration of the tumor tissue, elevated levels of serum IL-1β and TNF-α and an increase in the activities of both SDH and LDH in EAC cells. The gene discussed is TNF; the disease is neoplasm.